Market Overview:
The global diabetes devices market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of diabetes, technological advancements in diabetes devices, and rising awareness about diabetes management. Based on type, the global diabetes devices market is segmented into blood glucose meters, lancets, blood glucose testing strips, continuous glucose monitoring (CGM) devices, insulin syringes, insulin pumps, insulin pens and injection needles. The blood glucose meters segment is expected to account for the largest share of the global diabetic device market in 2018. This can be attributed to the increasing demand for technologically advanced blood glucose meters that offer features such as Bluetooth connectivity and cloud storage facilities. Based on application type; hospital-based applications are expected to dominate the overall diabetic device market during forecast period owing high adoption rates across developed countries coupled with rising number of hospital admissions due to uncontrolled or poorly managed diabetes patients globally . However , personal use based applications are anticipated witness highest CAGR over forecast period owing growing trend among people towards self-monitoring their sugar levels which would eventually lead better control over disease progression .
Product Definition:
A diabetes device is a tool used to monitor blood sugar levels in people with diabetes. There are many different types of devices, including meters that test blood sugar levels, insulin pumps, and Continuous Glucose Monitors (CGMs). Diabetes devices are important because they help people with diabetes manage their disease by providing accurate information about their blood sugar levels.
Blood glucose meters:
Blood glucose meters is a device used to measure the blood sugar level of an individual. It's major function is to provide information about the amount of carbohydrate in the body which helps in managing diabetes. Blood glucose meters are classified into two types: Self-monitoring devices and insulin delivery devices.
Global Blood Glucose Meters, Diabetes Devices Market Size, Share & Trends Analysis Report By Type (Self-Monitoring Devices.
Lancets:
Lancets are used for drawing blood from patients. It is a thin, hollow tube made of metal or plastic and coated with a material that causes blood to clot when inserted into the skin. The lancet device consists of two parts; the needle and syringe. The needle is attached to the syringe by means of a hypodermic cannula which enables easy access to subcutaneous veins or arteries through puncture-resistant skin.
Application Insights:
The personal use segment dominated the global diabetes devices market in 2017. The growing prevalence of diabetes and increasing awareness about the availability of advanced products are some of the key factors driving this segment. For instance, as per a study published by Diabetes Research Institute in 2018, around 40% to 60% patients with type 2 diabetes have low self-esteem regarding their disease due to lack of knowledge about available treatment options. Such trends indicate a high potential for growth in personal use devices over the forecast period.
Clinic is expected to be one of the fastest-growing segments during the forecast period owing to an increase in demand for better diagnosis and treatment methods among patients suffering from various types of chronic diseases such as heart diseases, kidney failure, vision problems etc., which require regular monitoring and blood tests throughout their lifetime. Thus, rising demand for these devices at clinics is expected drive this segment significantly over next few years.
Regional Analysis:
North America dominated the global diabetes devices market in 2017. The presence of a large number of manufacturers and suppliers, favorable reimbursement policies, and increasing prevalence of diabetes are some factors attributing to its largest share. In addition, growing awareness about DTC testing is expected to further boost the regional market growth over the forecast period.
Asia Pacific is anticipated to witness lucrative CAGR during the forecast period owing to rising disposable income levels and improving economic conditions in emerging countries such as India & China & South Korea etcetera etcetera etcetera such as Japan). Moreover, an increase in healthcare expenditure by governments along with rising awareness about advanced products for diabetes management are other factors driving this region’s growth over the next eight years.
Growth Factors:
- Increasing prevalence of diabetes: The global prevalence of diabetes is increasing at an alarming rate. This is primarily due to the changing lifestyle and dietary habits of people across the world. As a result, there is a growing demand for diabetes devices and therapies.
- Technological advancements: Diabetes devices are constantly evolving with new technological advancements being made in the field regularly. This has led to increased accuracy and efficiency in diagnosing and managing diabetes patients.
- Growing awareness about diabetes: There is a growing awareness about diabetes among people all over the world, thanks to various campaigns by healthcare organizations as well as governments globally. This has led to an increase in demand for diabetic devices and therapies worldwide..
Scope Of The Report
Report Attributes
Report Details
Report Title
Diabetes Devices Market Research Report
By Type
Blood glucose meters, Lancets, Blood glucose testing strips, Continuous glucose monitoring devices, Insulin syringes, Insulin pumps, Insulin pens and injection
By Application
Hospital, Personal Use, Clinic
By Companies
Medtronic, Sanofi, Bayer, Becton, Dickinson and Company, Novo Nordisk, Abbott Laboratories, Roche, Johnson & Johnson
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
250
Number of Tables & Figures
175
Customization Available
Yes, the report can be customized as per your need.
Global Diabetes Devices Market Report Segments:
The global Diabetes Devices market is segmented on the basis of:
Types
Blood glucose meters, Lancets, Blood glucose testing strips, Continuous glucose monitoring devices, Insulin syringes, Insulin pumps, Insulin pens and injection
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Personal Use, Clinic
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Medtronic
- Sanofi
- Bayer
- Becton
- Dickinson and Company
- Novo Nordisk
- Abbott Laboratories
- Roche
- Johnson & Johnson
Highlights of The Diabetes Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Blood glucose meters
- Lancets
- Blood glucose testing strips
- Continuous glucose monitoring devices
- Insulin syringes
- Insulin pumps
- Insulin pens and injection
- By Application:
- Hospital
- Personal Use
- Clinic
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Diabetes Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Diabetes devices are medical devices that help people with diabetes manage their blood sugar levels. Diabetes devices can include insulin pumps, glucose meters, and other medical equipment.
Some of the key players operating in the diabetes devices market are Medtronic, Sanofi, Bayer, Becton, Dickinson and Company, Novo Nordisk, Abbott Laboratories, Roche, Johnson & Johnson.
The diabetes devices market is expected to register a CAGR of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Diabetes Devices Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Diabetes Devices Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Diabetes Devices Market - Supply Chain
4.5. Global Diabetes Devices Market Forecast
4.5.1. Diabetes Devices Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Diabetes Devices Market Size (000 Units) and Y-o-Y Growth
4.5.3. Diabetes Devices Market Absolute $ Opportunity
5. Global Diabetes Devices Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Diabetes Devices Market Size and Volume Forecast by Type
5.3.1. Blood glucose meters
5.3.2. Lancets
5.3.3. Blood glucose testing strips
5.3.4. Continuous glucose monitoring devices
5.3.5. Insulin syringes
5.3.6. Insulin pumps
5.3.7. Insulin pens and injection
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Diabetes Devices Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Diabetes Devices Market Size and Volume Forecast by Application
6.3.1. Hospital
6.3.2. Personal Use
6.3.3. Clinic
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Diabetes Devices Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Diabetes Devices Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Diabetes Devices Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Diabetes Devices Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Diabetes Devices Demand Share Forecast, 2019-2026
9. North America Diabetes Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Diabetes Devices Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Diabetes Devices Market Size and Volume Forecast by Application
9.4.1. Hospital
9.4.2. Personal Use
9.4.3. Clinic
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Diabetes Devices Market Size and Volume Forecast by Type
9.7.1. Blood glucose meters
9.7.2. Lancets
9.7.3. Blood glucose testing strips
9.7.4. Continuous glucose monitoring devices
9.7.5. Insulin syringes
9.7.6. Insulin pumps
9.7.7. Insulin pens and injection
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Diabetes Devices Demand Share Forecast, 2019-2026
10. Latin America Diabetes Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Diabetes Devices Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Diabetes Devices Market Size and Volume Forecast by Application
10.4.1. Hospital
10.4.2. Personal Use
10.4.3. Clinic
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Diabetes Devices Market Size and Volume Forecast by Type
10.7.1. Blood glucose meters
10.7.2. Lancets
10.7.3. Blood glucose testing strips
10.7.4. Continuous glucose monitoring devices
10.7.5. Insulin syringes
10.7.6. Insulin pumps
10.7.7. Insulin pens and injection
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Diabetes Devices Demand Share Forecast, 2019-2026
11. Europe Diabetes Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Diabetes Devices Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Diabetes Devices Market Size and Volume Forecast by Application
11.4.1. Hospital
11.4.2. Personal Use
11.4.3. Clinic
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Diabetes Devices Market Size and Volume Forecast by Type
11.7.1. Blood glucose meters
11.7.2. Lancets
11.7.3. Blood glucose testing strips
11.7.4. Continuous glucose monitoring devices
11.7.5. Insulin syringes
11.7.6. Insulin pumps
11.7.7. Insulin pens and injection
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Diabetes Devices Demand Share, 2019-2026
12. Asia Pacific Diabetes Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Diabetes Devices Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Diabetes Devices Market Size and Volume Forecast by Application
12.4.1. Hospital
12.4.2. Personal Use
12.4.3. Clinic
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Diabetes Devices Market Size and Volume Forecast by Type
12.7.1. Blood glucose meters
12.7.2. Lancets
12.7.3. Blood glucose testing strips
12.7.4. Continuous glucose monitoring devices
12.7.5. Insulin syringes
12.7.6. Insulin pumps
12.7.7. Insulin pens and injection
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Diabetes Devices Demand Share, 2019-2026
13. Middle East & Africa Diabetes Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Diabetes Devices Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Diabetes Devices Market Size and Volume Forecast by Application
13.4.1. Hospital
13.4.2. Personal Use
13.4.3. Clinic
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Diabetes Devices Market Size and Volume Forecast by Type
13.7.1. Blood glucose meters
13.7.2. Lancets
13.7.3. Blood glucose testing strips
13.7.4. Continuous glucose monitoring devices
13.7.5. Insulin syringes
13.7.6. Insulin pumps
13.7.7. Insulin pens and injection
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Diabetes Devices Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Diabetes Devices Market: Market Share Analysis
14.2. Diabetes Devices Distributors and Customers
14.3. Diabetes Devices Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Medtronic
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Sanofi
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Bayer
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Becton
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Dickinson and Company
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Novo Nordisk
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Abbott Laboratories
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Roche
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Johnson & Johnson
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
